Retractable Technologies, Inc. (NYSEAMERICAN:RVP) CEO Thomas J. Shaw purchased 13,900 shares of the business’s stock in a transaction on Wednesday, February 13th. The stock was purchased at an average cost of $0.73 per share, with a total value of $10,147.00. Following the acquisition, the chief executive officer now owns 13,949,831 shares in the company, valued at $10,183,376.63. The purchase was disclosed in a legal filing with the SEC, which is available at this link.
Retractable Technologies stock opened at $0.74 on Friday. Retractable Technologies, Inc. has a 12 month low of $0.54 and a 12 month high of $1.08.
Get Retractable Technologies alerts:
Retractable Technologies (NYSEAMERICAN:RVP) last posted its quarterly earnings results on Thursday, November 15th. The company reported ($0.01) EPS for the quarter. The business had revenue of $9.86 million during the quarter.
An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC lifted its stake in Retractable Technologies, Inc. (NYSEAMERICAN:RVP) by 20.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 692,623 shares of the company’s stock after buying an additional 118,723 shares during the period. Renaissance Technologies LLC owned about 2.12% of Retractable Technologies worth $499,000 at the end of the most recent reporting period.
COPYRIGHT VIOLATION NOTICE: “Thomas J. Shaw Acquires 13,900 Shares of Retractable Technologies, Inc. (RVP) Stock” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4158999/thomas-j-shaw-acquires-13900-shares-of-retractable-technologies-inc-rvp-stock.html.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps.
Further Reading: How can you know how many shares are floating?